J
Jing Ji
Publications - 6
Citations - 64
Jing Ji is an academic researcher. The author has contributed to research in topics: Gene silencing & Ubiquitin ligase. The author has an hindex of 1, co-authored 6 publications receiving 5 citations.
Papers
More filters
Journal ArticleDOI
Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2
Bin Liu,Liping Xiang,Jing Ji,Wei Liu,Ying Chen,Mingfeng Xia,Yuejun Liu,Wen-Yue Liu,Peiwu Zhu,Yi Jin,Yu Han,Jieli Lu,Xiaoying Li,Ming-Hua Zheng,Yan Lu +14 more
TL;DR: In this article, the authors identified increased expression of Sparcl1, a secreted glycoprotein, in the WAT from NASH mice, and showed that both chronic injection and overexpression of SPARcl1 exaggerated hepatic inflammation and liver injury in mice.
Journal ArticleDOI
Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells.
TL;DR: In this article, the EZH2-SOX9-TNFRSF11A axis and the activity of NF-κB signaling in prostate cancer (PCa) cells were analyzed using Limma R package Western blot, real-time PCR and luciferase reporter assays.
Journal ArticleDOI
FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.
Mei Ji,Zhao Zhao,Yue Li,Penglin Xu,Jia Shi,Zhe Li,Kaige Wang,Xiaotian Huang,Jing Ji,Wei Liu,Bin Liu +10 more
TL;DR: In this paper, an E3 ubiquitin ligase was found to be a tumor suppressor in ovarian cancer, and patients with the relatively high expression level of FBXO16 have a better prognosis.
Journal ArticleDOI
Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis.
Ping Liu,Xiaoji Cong,Shengjie Liao,Xing-Long Jia,Xiaomin Wang,Wei Dai,Linhui Zhai,Lei Zhao,Jing Ji,Duan Ni,Zhiwei Liu,Yulu Chen,Lulu Pan,Wei Liu,Jian Zhang,Jian Zhang,Min Huang,Bin Liu,Minjia Tan +18 more
TL;DR: In this article, the authors performed a system-wide investigation of phospho-dependent SKP1-CUL1-F-box (SCF) substrates and identified broad phosphorylation-dependent SCF substrates.
Journal ArticleDOI
SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer
Estelle Stubbs,Jing Ji,Mengru Xie,Qilan Qian,Yuxin Xu,Wen Shi,Zefeng Chen,Dexu Ren,Wenwen Liu,Xingbei He,Mingxiao Lv,Jinming Ma,Wei Liu,Aimin Li,Bin Liu +14 more
TL;DR: In this paper, the authors showed that UGT8 was selectively highly expressed in non-small cell lung cancer (NSCLC) and associated with worse prognosis, and they showed that inhibition of glycolysis by 2-deoxy-d -glucose (2-DG) significantly impaired the pro-proliferation function of UGT 8 in NSCLC cells.